Japan diagnostic lab market is anticipated to register a robust growth in the forecast period, 2023-2027. The rising number of cases of chronic and infectious diseases, along with the evolving healthcare environment are the primary factors driving the diagnostic lab market across Japan. In addition to this, the increasing number of patients suffering from infectious diseases, including gastrointestinal, respiratory, STDs (sexually transmitted diseases), etc., is projected to escalate the demand for diagnostic devices, which propels the diagnostic lab market in Japan. With the growing utilization of diagnostic testing and expanding awareness towards point of care testing are further augmenting the market growth in Japan. Also, the sudden outbreak of COVID-19 pandemic has escalated the demand for diagnostic testing which includes clinical chemistry, immunology, hematology, etc., is bolstering the growth of the diagnostic lab market across Japan. Besides this, continuous technological advancements, and elevating adoption of novel technologies in the healthcare industry are expected to drive the Japan diagnostic lab market in the coming years.
Diagnosis of Chronic and Infectious Diseases Fuels the Market Growth
Infectious disease diagnosis refers to the laboratory test which is performed by the skilled lab technicians under the guidance of physicians. The diagnostic lab market is growing due to rise in prevalence of numerous chronic and infectious disease such as influenza, HIV, AIDS, COVID-19, and hepatitis. Diagnostic lab centers are getting funds from private & public organization to enhance the infrastructure of testing center on account of the increasing infectious and chronic diseases. Along with this, the technological advancements in the field of infectious diseases diagnostics are also contributing to the market growth. Inflating awareness among individuals for early diagnosis and management of infectious disease as well as growing number of information technology system to launch advanced diagnostic devices are expected to drive the Japan diagnostic labs market in the upcoming years.
Growing Demand for Point-of-Care Diagnostic Test Boost the Market Growth
The rising prevalence of several chronic diseases, including cancer, gastrointestinal ailments, and respiratory disorder is propelling the need for point-of-care diagnostic test in the country. Additionally, the sudden outbreak of COVID-19 has escalated the demand for rapid testing kits which is further supporting the market growth. Furthermore, government bodies of Japan are taking initiatives to increase the adoption of point-of-care testing devices to diagnose the infectious diseases. The shifting preference towards the home-based healthcare and self-testing is supporting the market growth. Increase in number of clia-waved POC tests and expansion in healthcare expenditure across the globe are also bolstering the growth of the diagnostic market. The rising awareness regarding the POC testing devices through conferences and events is further anticipated to augment the market growth in the coming years.
Incorporation of Advanced Technologies is Projected to Augment the Market Growth
The innovations of advanced testing kits in the diagnostic labs are giving the test result at the earliest which is escalating the demand for diagnostic labs across Japan. In healthcare industry, the introduction of artificial intelligence is replacing labor-intensive and time-consuming operations with rapid, remote-accessible, and real-time solutions for diagnosis and disease prevention. Technological advancements also include Next Generation Sequencing (NGS) which is upgrading the results of the testing. Innovative technologies made the user friendly and portable devices for people to diagnose the diseases with the accurate results. Numerous leading market players are launching disposable test cartridges and microprocessor-based analyzers to diagnose infectious diseases at home which is expected to grow Japan diagnostic labs market at a significant rate over the forecasted period.
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
The Japan diagnostic labs market is segmented into provider type, test type, end user, and competitive landscape. Based on provider type, the market is divided into Hospital, Stand-Alone Centre, Diagnostic Chains. Based on test type, the market is divided into
Market Players
Miraca Holdings Inc., Eurofins Scientific (Genetic Lab), BML, Inc., Forest Japan Medical Centre, H.U. Group are among the leading market players operating in the Japan diagnostic labs market.
Attribute | Details |
Base Year | 2021 |
Historic Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Provider Type · Test Type · End User |
Regional scope | Hokkaido & Tohoku, Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu. |
Key companies profiled | Miraca Holdings Inc., Eurofins Scientific (Genetic Lab), BML, Inc., Forest Japan Medical Centre, H.U. Group |
Customization scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |